Medical Countermeasures New Insights Into Tularemia Pathogen May Inform Next-Generation Medical CountermeasuresGlobal Biodefense StaffMay 14, 2026
Medical Countermeasures When Mpox Strikes the Eye: A Case for Combination Antiviral TherapyGlobal Biodefense StaffApril 16, 2026
Medical Countermeasures Smallpox Preparedness Contracts Top $60 Million as U.S. and International Partners Bolster Biodefense StockpilesGlobal Biodefense StaffMarch 25, 2026
Renowned Tick Immunobiologist to Develop Lyme Disease Vaccine Under New $3.5M Federal Grant Contracts + Grants October 7, 2020 …
The Challenges of Vaccine Cold-Chain Distribution Must Be Met to End the Pandemic Medical Countermeasures October 5, 2020 …
Vaxxas Awarded $22M to Advance Needle-Free Vaccine Technology for Pandemic Response Industry News October 5, 2020 …
Operation Warp Speed’s Big Vaccine Contracts Could Stay Secret Medical Countermeasures September 29, 2020 …
Basilea Awarded Additional Funding from U.S. Medical Countermeasure Program for Ceftobiprole Development Antimicrobial Resistance September 28, 2020 …
Remdesivir: Second Mechanism of Action Against SARS-CoV-2 Revealed in New Study Medical Countermeasures September 23, 2020 …
NIH Expands COVID-19 Convalescent Plasma Clinical Trials Medical Countermeasures September 22, 2020 …
HHS Pushes Out COVID-19 Mass Vaccination Playbook, Distribution Strategy Medical Countermeasures September 16, 2020 …
The Big 3 Infectious Diseases Besides COVID-19 Scientists Are Trying to Find a Vaccine For Medical Countermeasures September 14, 2020 …
COVID-19 Industry Rivals Plan Joint Pledge on Vaccine Safety Medical Countermeasures September 4, 2020 …
The Challenge of Vaccine Cold Chain Logistics: How a Chemical ‘Casing’ Could Save Lives Medical Countermeasures September 4, 2020 …
Lessons From Hydroxychloroquine: Improving FDA’s Authorization and Approval Process Medical Countermeasures August 31, 2020 …
USAMRIID Scientists Engineer First Lethal Mouse Model for COVID-19 Medical Countermeasures August 27, 2020 …
Vaccine Approval Is Just The Beginning – Huge Production Challenges Await Medical Countermeasures August 24, 2020 …
UC Riverside Scientists Use AI to Drive COVID Countermeasure Discovery Medical Countermeasures August 12, 2020 …
NIAID-Led Study of COVID-19 mRNA Vaccine Supports Advance to Phase 3 Human Trials Medical Countermeasures July 28, 2020 …
Moderna’s COVID-19 Vaccine Generally Well Tolerated in Ongoing Phase 1 Trial Medical Countermeasures July 14, 2020 …
Many Flu Strains May Be Capable of Mutating to Escape Universal-Vaccine Antibodies Medical Countermeasures June 24, 2020 …
